Mereo BioPharma Group PLC ADR Cash Flow Quality Index

Latest as of September 2021: -23.77x

Mereo BioPharma Group PLC ADR cash flow quality index. Mereo BioPharma Group PLC ADR (MREO) has a Cash Flow Quality Index of -23.77x as of September 2021. Operating cash flow of $-10.20 Million is below net income of $429.19K, suggesting accrual-heavy earnings not yet converted to cash. See Mereo BioPharma Group PLC ADR financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-23.77x

Operating CF / Net Income

Operating Cash Flow

$-10.20 Million

USD

Net Income

$429.19K

USD

Data as of

Sep 2021

Most recent filing

Cash Flow Quality Index of Mereo BioPharma Group PLC ADR (2021–2021)

Cash flow quality index of Mereo BioPharma Group PLC ADR from 2021 to 2021. Historical Cash Flow Quality Index for Mereo BioPharma Group PLC ADR across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Mereo BioPharma Group PLC ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Mereo BioPharma Group PLC ADR Cash Flow Quality Index by Year (2021–2021)

Mereo BioPharma Group PLC ADR cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Mereo BioPharma Group PLC ADR. For the full cash flow conversion analysis, see Mereo BioPharma Group PLC ADR (MREO) cash flow conversion.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2021	-0.37x	$-7.07 Million	$19.22 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.